Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biose Industrie
Aurillac, Auvergne-Rhône-Alpes, Francebiose.com ↗
- Ownership
- Private
- Employees
- ~300
- Development stage
- Commercial
01
Overview
Biose Industrie does not develop its own therapeutics but serves as a world-leading CDMO specializing in the process development, scale-up, and GMP manufacture of live biotherapeutic products and next-generation probiotics for clients globally. The company supports projects from preclinical through commercial launch stages. It has demonstrated expertise in regulatory compliance with ANSM, EMA, FDA standards. Clinical results pertain to client programs manufactured by Biose.
- Therapeutic areas
- GastroenterologyMetabolic DisordersImmunologyWomen's Health
- Modalities
- Live biotherapeutic product therapyMicrobial therapyProbiotics (Next Generation Probiotics)Biologic
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Biose Industrie.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biose Industrie.